Aerovance 
Welcome,         Profile    Billing    Logout  
 2 Products   15 Diseases  2 Products   1 Trial   141 News 
1 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Bikunin (ulinastatin) / Aerovance
2005-005044-40: A Phase 2a Study To Investigate The Effects Of AER 002 On Mucociliary Clearance In Subjects With Chronic Obstructive Pulmonary Disease (COPD)

Ongoing
2
20
Europe
Recombinant truncated SPINT2 Protease inhibitor, AER 002,
Aerovance, Inc
Chronic Obstructive Pulmonary Disease (COPD)
 
 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Bikunin (ulinastatin) / Aerovance
2005-005044-40: A Phase 2a Study To Investigate The Effects Of AER 002 On Mucociliary Clearance In Subjects With Chronic Obstructive Pulmonary Disease (COPD)

Ongoing
2
20
Europe
Recombinant truncated SPINT2 Protease inhibitor, AER 002,
Aerovance, Inc
Chronic Obstructive Pulmonary Disease (COPD)
 
 

Download Options